Syed Z. Imam
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: National Institutes of Health (2007); United States Food and Drug Administration (2001–2022); University of Ulster (1997); The University of Texas at San Antonio Health Science Center (2006–2013); Jamia Hamdard (1999–2002); Audie L. Murphy Memorial VA Hospital (2010); National Institute on Aging (2005–2007); South Texas Veterans Health Care System (2005–2007); The University of Texas Health Science Center at Houston (2005–2013)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Syed Z. Imam is a faculty member at the National Center for Toxicological Research with a research focus on understanding the mechanisms of neurodegeneration. His work investigates the role of autophagy and protein aggregation in dopaminergic degeneration, particularly in primary human neuronal models. Imam has published 61 papers, accumulating 2,897 citations, and holds an h-index of 30, recognizing him as a highly cited researcher. His recent publication in 2022 addresses autophagy and protein aggregation in the context of dopaminergic degeneration. Imam collaborates with several researchers at the National Center for Toxicological Research, including Susan M. Burks, Manuel Alejandro Ramirez-Lee, Syed F. Ali, and Aída Guzmán, with whom he has co-authored publications.
Metrics
- h-index: 30
- Publications: 61
- Citations: 2,903
Selected Publications
-
Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model (2022)
-
Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro (2019)
-
A Method for Sampling Rat Cerebrospinal Fluid with Minimal Blood Contamination: A Critical Tool for Biomarker Studies (2019)
-
Cytotoxicity profile of pristine graphene on brain microvascular endothelial cells (2019)
-
Drug discovery and development: Biomarkers of neurotoxicity and neurodegeneration (2018)
-
Characterization of uniaxial high-speed stretch as an in vitro model of mild traumatic brain injury on the blood-brain barrier (2018)
-
Ontogeny of Monoamine Neurotransmitters (2018)
-
Ontogeny of Second Messenger Systems (2018)
-
Blood–Brain Barrier: Physiological and Functional Considerations (2018)
-
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin study (2017)
-
Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier (2017)
-
Monoaminergic toxicity induced by cathinone phthalimide: An in vitro study (2017)
-
Tyrosine Kinase Inhibitors and Neurodegenerative Disorders (2016)
-
Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage (2015)
-
Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease (2013)
Collaboration Network
Top Collaborators
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
- Autophagy and protein aggregation as a mechanism of dopaminergic degeneration in a primary human dopaminergic neuronal model
Similar Researchers
Based on overlapping research topics